Genetic mutations are only counted in 5 to 10% of cases of BC development, and BRCA1 and BRCA2 are TSGs positioned on chromosomes 17 and 13, respectively, involved in genomic stability, encrypting nuclear protein, and repairing double DNA strand breaks. Here, BRCA2 is linked to breast cancer.